Standardized retrieval of side effects data for meta-analysis of safety outcomes: A feasibility study in acute sinusitis

Journal of Clinical Epidemiology

Volumn 55, Issue 6, 2002, Pages 619-626

  Ioannidis, John P A ^a,b   Chew, Priscilla ^b   Lau, Joseph ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute sinusitis; Antibiotics; Meta analysis; Safety; Side effects; Systematic review

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BRODIMOPRIM; CEFACLOR; CEFALEXIN; CEFETAMET; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFTIBUTEN; CEFUROXIME; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; LORACARBEF; PENICILLIN G; ROXITHROMYCIN; SPARFLOXACIN;

ACCURACY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG SAFETY; DRUG WITHDRAWAL; EVALUATION; FEASIBILITY STUDY; GASTROINTESTINAL TOXICITY; HOSPITALIZATION; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; META ANALYSIS; NAUSEA AND VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SINUSITIS; STANDARDIZATION;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; FEASIBILITY STUDIES; GASTROINTESTINAL DISEASES; HUMANS; LOGISTIC MODELS; META-ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SINUSITIS;

EID: 0036280951     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(02)00393-1     Document Type: Article

References (23)

1. An evidence-based approach to individualizing treatment
2. Improving the quality of reporting of randomized controlled trials. The CONSORT statement
3. The Cochrane Collaboration
4. Reporting of safety data from randomised trials
5. Completeness of safety reporting in randomized trials: An evaluation of 7 medical areas
6. Are amoxicillin and folate inhibitors as effective as other antibiotics for acute sinusitis?
7. Statistical aspects of the analysis of data from retrospective studies of disease
8. Meta-analysis in clinical trials
9. Publication bias: The case for an international registry of clinical trials
10. Design and implementation of a national clinical trials registry
11. Practical methodology of meta-analyses (overviews) using updated individual patient data
12. Well-known signatory does not affect response to a request for information from authors of clinical trials: A randomized controlled trial
13. Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: A meta-analysis
14. Gastrointestinal safety profile of meloxicam: A meta-analysis and systematic review of randomised controlled trials
15. The evaluation of the safety and tolerability of two formulations of cyclosporine: Neural and sandimmune. A meta-analysis
16. Safety of nifedipine in angina pectoris: A meta-analysis
17. Meta-analysis of randomized controlled trials as a method of estimating rare complications of non-steroidal anti-inflammatory drug therapy
18. How do Cochrane reviewers address adverse effects of drug therapy?
19. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel group randomized trials
20. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials
21. The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomised doxycycline trial
22. State of the evidence: Current status and prospect of meta-analysis in infectious diseases